Ioannis Anagnostopoulos Selected Research

Ioannis Anagnostopoulos Research Topics

Disease

18	Neoplasms (Cancer) 12/2020 - 05/2002
15	Lymphoma (Lymphomas) 11/2023 - 07/2002
14	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2022 - 12/2003
12	Hodgkin Disease (Hodgkin's Disease) 06/2022 - 04/2002
8	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 04/2004
6	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2021 - 08/2002
5	Inflammation (Inflammations) 11/2023 - 02/2006
5	Infections 08/2021 - 01/2014
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 11/2008
4	Hairy Cell Leukemia 12/2020 - 08/2007
3	Atrial Fibrillation 10/2023 - 12/2019
3	Leukemia 01/2022 - 12/2014
3	Carcinogenesis 07/2017 - 08/2002
3	Disease Progression 01/2017 - 02/2012
2	Pathologic Complete Response 10/2022 - 09/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2014
2	Epstein-Barr Virus Infections 01/2022 - 12/2020
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2020 - 01/2017
2	Hypertension (High Blood Pressure) 04/2020 - 02/2020
2	Fibrosis (Cirrhosis) 01/2017 - 11/2015
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 04/2006
2	Hematologic Neoplasms (Hematological Malignancy) 10/2014 - 07/2011
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2008 - 12/2005
1	Heart Failure 02/2023
1	Death (Near-Death Experience) 04/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2022
1	Cardiomyopathies (Cardiomyopathy) 04/2022
1	Plasmablastic Lymphoma 05/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Persistent Infection 01/2021
1	Sepsis (Septicemia) 01/2021
1	Myocardial Infarction 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2020
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 12/2019
1	Crohn Disease (Crohn's Disease) 12/2019
1	Thrombosis (Thrombus) 07/2017
1	Neoplasm Metastasis (Metastasis) 04/2017
1	Whipple Disease (Whipple's Disease) 01/2017

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 10/2022 - 04/2007
7	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2004
5	AntibodiesIBA 01/2017 - 02/2006
4	ParaffinIBA 04/2017 - 01/2017
4	Immunoglobulins (Immunoglobulin)IBA 02/2006 - 04/2002
3	Formaldehyde (Formol)FDA Link 04/2017 - 01/2008
3	Prednisone (Sone)FDA LinkGeneric 02/2017 - 04/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2017 - 04/2006
3	Vincristine (Oncovin)FDA LinkGeneric 02/2017 - 04/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017 - 04/2006
3	CytokinesIBA 01/2017 - 10/2008
3	NF-kappa B (NF-kB)IBA 12/2005 - 08/2002
2	ChromatinIBA 11/2023 - 10/2014
2	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2020
2	Pyridinolcarbamate (P23)IBA 10/2021 - 04/2009
2	Anaplastic Lymphoma KinaseIBA 10/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2017
2	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2020 - 12/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 04/2007
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018 - 08/2002
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 09/2011
2	Proteins (Proteins, Gene)FDA Link 03/2014 - 02/2006
2	Alemtuzumab (Campath)FDA Link 07/2011 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 10/2005
2	Interferon-gamma (Interferon, gamma)IBA 04/2010 - 10/2009
2	Monoclonal AntibodiesIBA 01/2008 - 05/2005
2	AntigensIBA 02/2006 - 05/2005
1	InterferonsIBA 11/2023
1	pirfenidoneIBA 02/2023
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2023
1	empagliflozinIBA 02/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2023
1	MEF2 Transcription FactorsIBA 06/2022
1	GadoliniumIBA 04/2022
1	Keratins (Keratin)IBA 05/2021
1	ProcalcitoninIBA 01/2021
1	Nucleic AcidsIBA 12/2020
1	Messenger RNA (mRNA)IBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	metreleptinIBA 12/2019
1	LeptinIBA 12/2019
1	AntimetabolitesIBA 11/2018
1	Calcineurin InhibitorsIBA 11/2018
1	plasma protein Z (protein Z)IBA 07/2017
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2017
1	Plasminogen Activator Inhibitor 1IBA 07/2017
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2017
1	Hyaluronic Acid (Hyaluronan)IBA 04/2017
1	Amylases FDA Link 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017

Therapy/Procedure

15	Therapeutics 04/2022 - 01/2007
12	Drug Therapy (Chemotherapy) 10/2022 - 12/2003
3	Organ Transplantation 10/2022 - 12/2003
3	Blood Pressure Monitors 04/2020 - 12/2019
3	Aftercare (After-Treatment) 12/2014 - 04/2007
3	Transplantation 10/2012 - 07/2011
2	Catheter Ablation 10/2023 - 08/2022
2	Hematopoietic Stem Cell Transplantation 01/2022 - 08/2014
2	Radiotherapy 08/2021 - 02/2007
1	Defibrillators (Defibrillator) 04/2022
1	Consolidation Chemotherapy 01/2022
1	Breast Implants (Breast Implant) 01/2021